Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody Pembrolizumab
Year: 2020
Type: article
Source: Molecular Cancer Therapeutics
Authors: Beth Hutchins, Gary C. Starling, Mark A. McCoy, Danuta Herzyk, Frederique M. Poulet, John Dulos, Liming Liu, Soonmo Peter Kang, Laurence Fayadat-Dilman, Mark Hsieh, Christine L. Andrews, Gulesi Ayanoglu, Constance Cullen, Rene de Waal Malefyt, Robert A. Kastelein, Sabine Le Saux, Julie Lee, Sophie Li, Dan Malashock, Svetlana Sadekova, George Soder, Hans van Eenennaam, Aarron Willingham, Ying Yu, Michel Streuli, Gregory J. Carven, Andrea van Elsas
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Merck
OpenAlex ID: W3013236696